Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-2 of 2
Keywords: Phosphodiesterase 5 inhibitor
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Further Areas
Takahira Kuno, Kenji Tamura, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Kohji Sawada, Masaharu Yasuda, Hironobu Watanabe, Fumito Komatsu, Hajime Kuroiwa, Motoaki Saito, Keiji Inoue
Journal:
Urologia Internationalis
Urol Int (2022) 106 (10): 1005–1011.
Published Online: 21 October 2021
.... Evaluation by age group Lower urinary tract symptoms Phosphodiesterase 5 inhibitor Prostatic hyperplasia Tadalafil Benign prostatic hypertrophy (BPH) is a disease that causes dysuria by increasing urethral resistance due to an enlarged prostate gland. While the cause is unknown, BPH is thought...
Journal Articles
Subject Area:
Further Areas
Ryosuke Takahashi, Yasuhiro Sumino, Minoru Miyazato, Hisae Nishii, Takuma Oshiro, Hiromitsu Mimata, Seiichi Saito, Masaki Yoshida, Masatoshi Eto
Journal:
Urologia Internationalis
Urol Int (2020) 104 (7-8): 587–593.
Published Online: 07 August 2020
... hyperplasia Phosphodiesterase 5 inhibitor Night-time voiding (nocturia) is one of the most bothersome symptoms in men with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH), and it is highly prevalent in community-dwelling men [ 1 ]. Pharmacological therapies with α1-blockers...
